To better understand the role of PD-1 inactivation in Tc17 responses and to exploit this for tumor therapy, PD-1-mediated effects were next analyzed to determine whether the regulation of Tc17 differentiation was either due to increased differentiation or simply to increased proliferation (47). The gene discussed is PDCD1; the disease is neoplasm.